Search

everythinglearnresearchcommunity

for

Search:↓

A 3-year-old with vitamin D-resistant rickets and severe hair loss died despite treatment, highlighting the need for improved management of the condition.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Low vitamin D3 is not linked to different levels of thyroid hormones in people with autoimmune thyroid disease.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Nitroglycerin ointment is now used to treat several skin conditions with fewer side effects.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The model and estimator can predict drug exposure in kidney transplant patients well.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Tailored treatment plans are crucial for managing canine dermatomyositis-like disease.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Dutasteride is a safe and effective treatment for hair loss.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.